We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Dade Behring Honored With Award

By Labmedica staff writers
Posted on 28 Feb 2005
The world's largest company solely dedicated to clinical diagnostics, Dade Behring (Deerfield, IL, USA), announced that it has received the 2004 Business Development Strategy Award for the in vitro diagnostics (IVD) marketplace in Asia and Japan.

The award was received from Frost & Sullivan (Palo Alto, CA, USA), an international consulting firm that presents the award each year to the company that has demonstrated the highest level of excellence in business development within its industry. More...
Based on predetermined analysis of new segments, the number of new customers, and commitment to business expansion, Dade Behring has been ranked number one in the industry.

"Dade Behring has done an exceptional job in the Japanese, Chinese, and Indian markets in achieving a very high level of customer satisfaction through their customer-centered product development,” said Mr. Raghavendra Chitta, a research analyst at Frost & Sullivan. "Innovation and sound business management are the cornerstones of their strategy and their success in Asia Pacific and Japan, making this company an ideal recipient of our strategy award for leadership.”

The award recognizes the company's ability to best perceive consumer needs, develop products and/or services that meet user needs, successfully introduce products or services to the industry, and identify new market segments to expand the existing customer base.

"Through dedication and a passionate commitment to addressing our customers' real needs, Dade Behring works to provide broad-based solutions to the challenges our customers face on a day-to-day basis,” said Jean-Luc Devleeschauwer, regional vice president, Asia Pacific/Japan, Dade Behring. "This award confirms that our high
standards have built trust and loyalty among our customers and have made us ‘people you can count on, with solutions you need.'”




Related Links:
Dade Behring

Gold Member
Blood Gas Analyzer
Stat Profile pHOx
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Hemodynamic System Monitor
OptoMonitor
Homocysteine Quality Control
Liquichek Homocysteine Control
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Immunology

view channel
Image: Whole-genome sequencing enables broader detection of DNA repair defects to guide PARP inhibitor cancer therapy (Photo courtesy of Illumina)

Whole-Genome Sequencing Approach Identifies Cancer Patients Benefitting From PARP-Inhibitor Treatment

Targeted cancer therapies such as PARP inhibitors can be highly effective, but only for patients whose tumors carry specific DNA repair defects. Identifying these patients accurately remains challenging,... Read more

Pathology

view channel
Image: AI models combined with DOCI can classify thyroid cancer subtypes (Photo courtesy of T. Vasse et al., doi 10.1117/1.BIOS.3.1.015001)

AI-Powered Label-Free Optical Imaging Accurately Identifies Thyroid Cancer During Surgery

Thyroid cancer is the most common endocrine cancer, and its rising detection rates have increased the number of patients undergoing surgery. During tumor removal, surgeons often face uncertainty in distinguishing... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.